Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVnCoV Co-administration with Influenza Vaccine in Adults 60+
NCT04848467Phase 3Withdrawn
- Sponsor
- Bayer
- Start
- Oct 2021
- Primary completion
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
01
Overview
A Phase 3 trial of zorecimeran in coronavirus disease 2019 (COVID-19), sponsored by Bayer. Planned start Oct 2021; status: withdrawn.
02
Drugs
zorecimeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04848467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848467.